Načítá se...
Pharmacogenetic diversification by alternative translation initiation: background channels to the fore: Commentary on Kisselbach et al., Br J Pharmacol 171: 5182–5194
This article is a Commentary on Kisselbach J, Seyler C, Schweizer PA, Gerstberger R, Becker R, Katus HA and Thomas D (2014). Modulation of K2P2.1 and K2P10.1 K+ channel sensitivity to carvedilol by alternative mRNA translation initiation. Br J Pharmacol 171: 5182–5194. doi: 10.1111/bph.12596
Uloženo v:
| Vydáno v: | Br J Pharmacol |
|---|---|
| Hlavní autor: | |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
John Wiley & Sons, Ltd
2015
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4562518/ https://ncbi.nlm.nih.gov/pubmed/24528336 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/bph.12630 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|